Cargando…
Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India
BACKGROUND: Bariatric endoscopy has emerged for non-surgical treatment of obesity, providing a treatment option for weight loss and associated comorbidities. Outcomes of endoscopic sleeve gastroplasty (ESG) of 12 months have been published by our team and there is a need for longer follow-up period...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034804/ https://www.ncbi.nlm.nih.gov/pubmed/36124467 http://dx.doi.org/10.4103/jmas.jmas_3_22 |
_version_ | 1784911287251107840 |
---|---|
author | Bhandari, Mahak Kosta, Susmit Reddy, Manoj Mathur, Winni Neto, Manoel Galvao Bhandari, Mohit |
author_facet | Bhandari, Mahak Kosta, Susmit Reddy, Manoj Mathur, Winni Neto, Manoel Galvao Bhandari, Mohit |
author_sort | Bhandari, Mahak |
collection | PubMed |
description | BACKGROUND: Bariatric endoscopy has emerged for non-surgical treatment of obesity, providing a treatment option for weight loss and associated comorbidities. Outcomes of endoscopic sleeve gastroplasty (ESG) of 12 months have been published by our team and there is a need for longer follow-up period understanding the effects of ESG techniques. AIM: This report emphasises on weight loss pattern in follow-up time points and monitors the post-procedure improvement in comorbidities with minimum 4-year follow-up of patients undergoing ESG at a single academic centre in India. SUBJECTS AND METHODS: This was a prospective cohort study. All procedures were performed by the same surgeon. Patients with a body mass index of >30 kg/m(2) (or >27 with comorbidities) underwent ESG for treatment of obesity. Patients were systematically followed yearly after their procedure. Data collected on the primary outcome and secondary outcomes were analysed and presented. RESULTS: 612 patients (69.3% female) with a mean age of 40.70 ± 12.66 years and mean body mass index of 34.30 ± 5.05 kg/m(2) underwent ESG. Out of 612 patients, follow-up rates for a 1-2-3 and 4 years were 93.1%, 90.2%, 81.7% and 81.9%, respectively. The mean percentage total body weight loss was 18.19% (95% confidence interval [CI]: 17.72–18.57) and %EWL was 49.30% (95% CI: 48.91–49.68) with 90% of participants-maintaining a percentage of total weight loss of ≥5% and 70% of patients maintaining an EWL of ≥25% at 4 years, respectively. Resolution/improvement of comorbidities was 51.2% cases of T2DM, 65.8% cases of hypertension, 73.6% cases of dyslipidaemia and 89.9% remission were in obstructive sleep apnoea. No patient required an emergency intervention, and there was no mortality or significant morbidity. CONCLUSIONS: This study shows acceptable results with ESG at 4 years in our unit. Regular monitoring by a multidisciplinary nurtures weight loss, resolution or improvement of comorbidities and improvement of quality of life with low perioperative complications. There is a need for more reports with this approach to determine the amount and duration of weight loss outcome and medical intervention. |
format | Online Article Text |
id | pubmed-10034804 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer - Medknow |
record_format | MEDLINE/PubMed |
spelling | pubmed-100348042023-03-24 Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India Bhandari, Mahak Kosta, Susmit Reddy, Manoj Mathur, Winni Neto, Manoel Galvao Bhandari, Mohit J Minim Access Surg Original Article BACKGROUND: Bariatric endoscopy has emerged for non-surgical treatment of obesity, providing a treatment option for weight loss and associated comorbidities. Outcomes of endoscopic sleeve gastroplasty (ESG) of 12 months have been published by our team and there is a need for longer follow-up period understanding the effects of ESG techniques. AIM: This report emphasises on weight loss pattern in follow-up time points and monitors the post-procedure improvement in comorbidities with minimum 4-year follow-up of patients undergoing ESG at a single academic centre in India. SUBJECTS AND METHODS: This was a prospective cohort study. All procedures were performed by the same surgeon. Patients with a body mass index of >30 kg/m(2) (or >27 with comorbidities) underwent ESG for treatment of obesity. Patients were systematically followed yearly after their procedure. Data collected on the primary outcome and secondary outcomes were analysed and presented. RESULTS: 612 patients (69.3% female) with a mean age of 40.70 ± 12.66 years and mean body mass index of 34.30 ± 5.05 kg/m(2) underwent ESG. Out of 612 patients, follow-up rates for a 1-2-3 and 4 years were 93.1%, 90.2%, 81.7% and 81.9%, respectively. The mean percentage total body weight loss was 18.19% (95% confidence interval [CI]: 17.72–18.57) and %EWL was 49.30% (95% CI: 48.91–49.68) with 90% of participants-maintaining a percentage of total weight loss of ≥5% and 70% of patients maintaining an EWL of ≥25% at 4 years, respectively. Resolution/improvement of comorbidities was 51.2% cases of T2DM, 65.8% cases of hypertension, 73.6% cases of dyslipidaemia and 89.9% remission were in obstructive sleep apnoea. No patient required an emergency intervention, and there was no mortality or significant morbidity. CONCLUSIONS: This study shows acceptable results with ESG at 4 years in our unit. Regular monitoring by a multidisciplinary nurtures weight loss, resolution or improvement of comorbidities and improvement of quality of life with low perioperative complications. There is a need for more reports with this approach to determine the amount and duration of weight loss outcome and medical intervention. Wolters Kluwer - Medknow 2023 2022-08-22 /pmc/articles/PMC10034804/ /pubmed/36124467 http://dx.doi.org/10.4103/jmas.jmas_3_22 Text en Copyright: © 2022 Journal of Minimal Access Surgery https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms. |
spellingShingle | Original Article Bhandari, Mahak Kosta, Susmit Reddy, Manoj Mathur, Winni Neto, Manoel Galvao Bhandari, Mohit Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India |
title | Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India |
title_full | Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India |
title_fullStr | Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India |
title_full_unstemmed | Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India |
title_short | Four-year outcomes for endoscopic sleeve gastroplasty from a single centre in India |
title_sort | four-year outcomes for endoscopic sleeve gastroplasty from a single centre in india |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034804/ https://www.ncbi.nlm.nih.gov/pubmed/36124467 http://dx.doi.org/10.4103/jmas.jmas_3_22 |
work_keys_str_mv | AT bhandarimahak fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia AT kostasusmit fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia AT reddymanoj fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia AT mathurwinni fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia AT netomanoelgalvao fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia AT bhandarimohit fouryearoutcomesforendoscopicsleevegastroplastyfromasinglecentreinindia |